Rixa Health review

What it is

Rixa Health is a direct-to-consumer functional-medicine telehealth practice whose services span medical weight loss, women's HRT, GLP-1s for teens, peptide therapy, testosterone restoration, thyroid health, men's sexual health and custom functional lab work. It also runs a supplement shop. Care is described as root-cause and preventive, with required monthly follow-ups during the first six months of a weight-loss program, and it operates cash-pay with HSA and FSA cards accepted.

How it works

Booked consultations with named clinicians rather than an anonymous asynchronous queue, which is the practice's real differentiator. Four providers are named with their degrees, training and years in practice, and all four are described as certified peptide specialists — the DOs as board-certified physicians and Mia Scott as an ANCC board-certified nurse practitioner. Its partner-pharmacies page names Belmar Pharma Solutions in Youngtown, Arizona; Red Rock Pharmacy in Springville, Utah; and Seven Cells Pharmacy in Stuart, Florida, each with a street address and phone number. Naming both the clinicians and the pharmacies is more accountability than almost anyone else in this batch offers. Two things temper it. The catalogue is opaque: the dedicated peptide-therapy page describes benefits — cellular regeneration, hormonal balance, immunity, weight management, anti-aging, cognition — without naming a single molecule, and directs you to discuss specifics at consult. And the coverage claim in its record is out of date; the live site states 42 states with Alaska, Arkansas, Hawaii, North Dakota and South Dakota listed as coming soon. Weight-loss patients are required to attend monthly follow-ups for the first six months, which is a genuine adherence-and-safety structure rather than a billing device. A $25 first-visit discount is advertised and excludes asynchronous visits, including the men's vitality flow where the one named peptide lives.

Pricing transparency

Its record described Rixa as having no public pricing. That is half right and the half that matters is the half we care about. GLP-1 pricing is published in detail — semaglutide in five levels from $195 to $310 and tirzepatide in six levels from $280 to $525, each stated per four-week or five-week block covering the visit and the pass-through cost of medication shipped by the compounding pharmacy. Those are weight-loss figures, they are billed by cycle rather than by calendar month, and they are not a peptide price. Peptide therapy is the part that genuinely is not published: the pricing page says only that peptide pricing varies and can be further discussed during your consult, pointing you to the peptides page — which, as above, names no peptide. So there is no peptide figure to quote and we are not quoting one. Before booking, ask which specific peptide is being proposed, at what dose and concentration, what a month costs, which of the three named pharmacies will prepare it, and whether the price includes the follow-up visits. Cash-pay only, with HSA and FSA cards accepted.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Rixa names its three partner compounding pharmacies, which is the disclosure that actually lets a patient check licensure, and compounded sterile preparations are still not reviewed by the FDA for purity and potency the way approved drugs are. On the evidence, there is exactly one molecule here we can assess, because it is the only one named. PT-141, or bremelanotide, is a melanocortin-receptor agonist and an unusual case on this board: the injectable is an FDA-approved drug, but for one narrow indication only — generalised hypoactive sexual desire disorder in premenopausal women. Prescribed to a man for erectile or libido complaints, as the men's vitality page implies, it is off-label use of an approved molecule, and a compounded version is not the approved product. Its known effects include nausea, flushing and transient blood-pressure rises, which is why the approved label restricts dosing frequency. Everything else on the peptide page is unassessable by design: a benefit list without a molecule cannot be checked against evidence, and a reader cannot be sent to a monograph for a compound nobody has named. The sexual-health line also carries sildenafil and tadalafil, which are conventional approved PDE5 inhibitors and a different matter entirely. Individual results vary.

Pros and watch-outs

The evidence behind what Rixa Health prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

How Rixa Health compares

A few alternatives worth a look, depending on what you’re optimizing for.

• RMRoyal Medical Center

  A named-molecule peptide catalogue under a long-practising physician, if you can load the site

  See Royal Medical Center →
• RHRxION Health

  A flat NAD⁺ price from a platform that says on the page what the evidence does not support

  See RxION Health →
• RMRemi Meds

  NAD⁺ buyers who want the weekly volume stated, not just a monthly fee

  See Remi Meds →